Be The Match BioTherapies - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Be The Match BioTherapies

investment firm

Summary
Investments
Exits
Employees

About

Be The Match BioTherapies® is built on the foundation established by our parent company.

https://bethematchbiotherapies.com/

Highlights

Employee Profiles

Details

Operating Status: Active

Investments

Number of Investments

Number of Lead Investments

5

0

Be The Match BioTherapies has made 5 investments. Their most recent investment was on Oct 31, 2019, when Tmunity Therapeutics raised $75M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Oct 31, 2019 Tmunity Therapeutics	Series B	$75M	Biotechnology	—
Apr 19, 2018 Tmunity Therapeutics	Series A	$35M	Biotechnology	—
Apr 9, 2018 Magenta Therapeutics	Series C	$52M	Biotechnology	—
Jan 23, 2018 Tmunity Therapeutics	Series A	$100M	Biotechnology	—
May 2, 2017 Magenta Therapeutics	Series B	$50M	Biotechnology	—

Employee Profiles

Number of Employee Profiles

2

Be The Match BioTherapies has 2 current employee profiles, including Executive Chris McClain

Executive

Executive

Exits

Be The Match BioTherapies has had 2 exits. Be The Match BioTherapies most notable exits include Tmunity Therapeutics , Magenta Therapeutics

Date	Company Name	Exit Type	Industry
Dec 20, 2022	Tmunity Therapeutics	M&A	Biotechnology	Detail
Jun 20, 2018	Magenta Therapeutics	IPO	Biotechnology	Detail